Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
Therapy of patients with pemphigus vulgaris with systemic corticosteroids may not be effective enough or lead to the development of severe adverse events that make it necessary to reduce the dose of corticosteroid. In such cases, it is possible to use the immunosuppressants. The literature review an...
Saved in:
Main Authors: | Vadim V. Chikin, Arfenya E. Karamova |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2024-12-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://vestnikdv.ru/jour/article/viewFile/16808/pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation
by: Katharina Hogrefe, et al.
Published: (2025-01-01) -
Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus Foliaceous
by: Dipankar De, et al.
Published: (2025-01-01) -
Prognostic Factors Predicting Remission Following Rituximab Therapy for Pemphigus Vulgaris
by: Tal Raviv, et al.
Published: (2025-01-01) -
Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
by: Mehmet Enes Güner, et al.
Published: (2025-01-01) -
A Study of Clinical Profile of Patients Presenting with Topical Corticosteroid Induced Facial Dermatoses
by: Abhineetha Hosthota, et al.
Published: (2024-12-01)